Fig. 6From: Assessment of degradability and endothelialization of modified poly L-lactic acid (PLLA) atrial septal defect (ASD) occluders over time in vivoPathological observation of PLLA filaments at 6 months after endovascular implantation. (A) PLLA filament of NO.1021; (B) PLLA filament of NO.1023; (C) PLLA filament of NO.1627. PLLA: poly L-lactideBack to article page